HDAC9 and diffuse large B-cell lymphoma: Eμ-HDAC9 tumors were also found to express variable levels of IRF4 (MUM1), a marker for GC B cells and plasma cells, and typically found in non-GC-type DLBCL (Fig. 4 and Table 1) (Falini et al., 2000).